Answers are grounded in this paper and cite their sources.
Observational analysis reveals no resistance mutations to dolutegravir in HIV-1 persistently infected tissues, suggesting a mechanism behind detectable activity.
Despite ongoing transcriptional activity, persistence of HIV-1 in deep tissues is not associated with the selection of DRMs to dolutegravir on intact proviruses. Our results suggest that the detectable transcriptional activity stems predominantly from defective proviral DNA.
No takes yet. Share an insight, caveat, or question.
Mchantaf et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: